Inhaled corticosteroids for chronic obstructive pulmonary diseaseCAZZOLA, Mario; ROGLIANI, Paola; NOVELLI, Lucia et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 18, pp 2489-2499, issn 1465-6566, 11 p.Article

The use of inhaled corticosteroids in the United Kingdom and the NetherlandsVAN STAA, T. P; COOPER, C; LEUFKENS, H. G. M et al.Respiratory medicine. 2003, Vol 97, Num 5, pp 578-585, issn 0954-6111, 8 p.Article

True device compliance: the need to consider both competence and contrivanceBRENNAN, Victoria K; OSMAN, Liesl M; GRAHAM, Hamilton et al.Respiratory medicine. 2005, Vol 99, Num 1, pp 97-102, issn 0954-6111, 6 p.Article

Clinical side effects during aerosol therapy : Cutaneous and ocular effects. DiscussionGELLER, David E; JANSSENS, Hettie.Journal of aerosol medicine. 2007, Vol 20, issn 0894-2684, S100-S109, SUP1Conference Paper

Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroidsMENCKEBERG, Tanja T; BOUVY, Marcel L; BRACKE, Madelon et al.British journal of clinical pharmacology. 2008, Vol 66, Num 2, pp 255-260, issn 0306-5251, 6 p.Article

Inhaled Fluticasone and the Hormonal and Inflammatory Response to Brief ExerciseSCHWINDT, Christina D; ZALDIVAR, Frank; ELIAKIM, Alon et al.Medicine and science in sports and exercise. 2010, Vol 42, Num 10, pp 1802-1808, issn 0195-9131, 7 p.Article

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPDVESTBO, Jerøen; SORIANO, Joan B; ANDERSON, Julie A et al.Respiratory medicine. 2004, Vol 98, Num 11, pp 1045-1050, issn 0954-6111, 6 p.Conference Paper

The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trialMARTIN, Richard J; SZEFLER, Stanley J; ISRAEL, Elliot et al.Journal of allergy and clinical immunology. 2007, Vol 119, Num 1, pp 73-80, issn 0091-6749, 8 p.Article

Particle size of inhaled corticosteroids: Does it matter?LEACH, Chet; COLICE, Gene L; LUSKIN, Allan et al.Journal of allergy and clinical immunology. 2009, Vol 124, Num 6, issn 0091-6749, S88-S93, SUPConference Paper

Use of medication and quality of life among patients with COPDESTEBAN, Cristobal; MORAZA, Javier; QUINTANA, Jose M et al.Respiratory medicine. 2006, Vol 100, Num 3, pp 487-495, issn 0954-6111, 9 p.Article

Relationship Between Changes in Inhaled Corticosteroid Use and Markers of Uncontrolled Asthma During PregnancyBLAIS, Lucie; FIROOZI, Faranak; KETTANI, Fatima-Zohra et al.Pharmacotherapy. 2012, Vol 32, Num 3, pp 202-209, issn 0277-0008, 8 p.Article

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program studyBREHM, John M; SCHUEMANN, Brooke; FUHLBRIGGE, Anne L et al.Journal of allergy and clinical immunology. 2010, Vol 126, Num 1, pp 52-58, issn 0091-6749, 7 p.Article

Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroidsKEOKI WILLIAMS, L; JOSEPH, Christine L; LAFATA, Jennifer E et al.Journal of allergy and clinical immunology. 2007, Vol 119, Num 1, pp 168-175, issn 0091-6749, 8 p.Article

Effect of inhaled corticosteroids on risk of development of cataract : a meta-analysisUBOWEJA, Anup; MALHOTRA, Samir; PANDHI, P et al.Fundamental & clinical pharmacology. 2006, Vol 20, Num 3, pp 305-309, issn 0767-3981, 5 p.Article

Inhaled combination therapy with long-acting β₂-Agonists and corticosteroids in stable COPDCAZZOLA, Mario; DAHL, Ronald.Chest. 2004, Vol 126, Num 1, pp 220-237, issn 0012-3692, 18 p.Article

The relationship of asthma medication use to perinatal outcomesSCHATZ, Michael; DOMBROWSKI, Mitchell P; LEVENO, Kenneth J et al.Journal of allergy and clinical immunology. 2004, Vol 113, Num 6, pp 1040-1045, issn 0091-6749, 6 p.Article

Fifty μg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FPGIANNINI, D; DI FRANCO, A; TONELLI, M et al.Respiratory medicine. 2003, Vol 97, Num 5, pp 463-467, issn 0954-6111, 5 p.Article

Inhaled corticosteroids and hospitalisation due to exacerbation of COPDBOURBEAU, J; ERNST, P; COCKCOFT, D et al.The European respiratory journal. 2003, Vol 22, Num 2, pp 286-289, issn 0903-1936, 4 p.Article

Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroidsGODON, P; BOULET, L.-P; MALO, J.-L et al.The European respiratory journal. 2002, Vol 20, Num 6, pp 1364-1369, issn 0903-1936, 6 p.Article

Severe Exacerbations and Decline in Lung Function in AsthmaO'BYRNE, Paul M; PEDERSEN, Seren; LAMM, Carl Johan et al.American journal of respiratory and critical care medicine. 2009, Vol 179, Num 1, pp 19-24, issn 1073-449X, 6 p.Article

Developing the ideal inhaled corticosteroidCERASOLI, Franklin.Chest. 2006, Vol 130, Num 1, issn 0012-3692, 54S-64S, SUPConference Paper

Efficacy of fluticasone propionate on lung function and symptoms in wheezy infantsHOFHUIS, Ward; VAN DER WIEL, Els C; NIEUWHOF, Eveline M et al.American journal of respiratory and critical care medicine. 2005, Vol 171, Num 4, pp 328-333, issn 1073-449X, 6 p.Article

Adherence logger for a dry powder inhaler: A new device for medical adherence researchBOGEN, Daniel; APTER, Andrea J.Journal of allergy and clinical immunology. 2004, Vol 114, Num 4, pp 863-868, issn 0091-6749, 6 p.Article

Skin manifestations of inhaled corticosteroids in COPD patients: Results from Lung Health Study IITASHKIN, Donald P; MURRAY, H. Eileen; SKEANS, Melissa et al.Chest. 2004, Vol 126, Num 4, pp 1123-1133, issn 0012-3692, 11 p.Article

Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonideNORJAVAARA, Ensio; DE VERDIER, Maria Gerhardsson.Journal of allergy and clinical immunology. 2003, Vol 111, Num 4, pp 736-742, issn 0091-6749, 7 p.Article